FEDERATED HERMES, INC. - ACER THERAPEUTICS INC ownership

ACER THERAPEUTICS INC's ticker is ACER and the CUSIP is 00444P108. A total of 31 filers reported holding ACER THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.01 and the average weighting 0.0%.

Quarter-by-quarter ownership
FEDERATED HERMES, INC. ownership history of ACER THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$299,000
-11.8%
114,091
-3.0%
0.00%0.0%
Q3 2020$339,000
-32.3%
117,673
-19.5%
0.00%0.0%
Q2 2020$501,000
+179.9%
146,097
+62.7%
0.00%0.0%
Q1 2020$179,000
-30.9%
89,770
+39.0%
0.00%0.0%
Q4 2019$259,000
+2490.0%
64,594
+1907.9%
0.00%
Q3 2019$10,0003,2170.00%
Other shareholders
ACER THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Nantahala Capital Management 1,136,416$1,049,3670.10%
Anson Funds Management LP 129,795$119,8530.02%
HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC 60,000$550.01%
Hudson Bay Capital Management LP 274,300$253,2890.00%
UBS Group AG 33$300.00%
RHUMBLINE ADVISERS 347$3200.00%
OSAIC HOLDINGS, INC. 200$1840.00%
WELLS FARGO & COMPANY/MN 132$1220.00%
NORTHERN TRUST CORP 22,231$20,5280.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of ACER THERAPEUTICS INC shareholders